Masaya Shigeno

Hepatic steatosis is a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C virus infection

Kazuyuki Ohata, Keisuke Hamasaki, Kan Toriyama et al. · Cancer · 2003 · 317 citations · Full text

Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivation

Masaya Shigeno, Kazuhiko Nakao, Tatsuki Ichikawa et al. · Oncogene · 2003 · 117 citations

Dr5 Upregulation, Cytokine, Signaling Pathway +14

Aspirin and NS-398 inhibit hepatocyte growth factor-induced invasiveness of human hepatoma cells

Seigou Abiru, Kazuhiko Nakao, Tatsuki Ichikawa et al. · Hepatology · 2002 · 112 citations

Does interferon-free direct-acting antiviral therapy for hepatitis C after curative treatment for hepatocellular carcinoma lead to unexpected recurrences of HCC? A multicenter study by the Japanese Red Cross Hospital Liver Study Group

Toshie Mashiba, Kouji Joko, Masayuki Kurosaki et al. · PLoS ONE · 2018 · 54 citations · Full text

The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study

Kaoru Tsuchiya, Masayuki Kurosaki, Azusa Sakamoto et al. · Cancers · 2021 · 54 citations · Full text